Canada adds that importing its drugs will not solve America's drug pricing problems.

Canada issued a warning Monday that it stands ready to defend its prescription drug supply from US importation plans—and also said the plans wouldn’t work for the US, anyway. “Bulk importation will not provide an effective solution to the problem of high drug prices in the US,” Health Canada said in a statement.

The defensive stance comes just days after the US Food and Drug Administration granted Florida authorization to directly import cheaper prescription drugs from Canada in an effort to help drag down America’s uniquely stratospheric drug pricing. Florida is the first state to win such an authorization, and Florida Governor Ron DeSantis celebrated it, claiming the drug imports will save the state “up to $180 million in the first year alone.” There are caveats, though. Before Florida can import any drugs, it must complete several obligations, including submitting to the FDA additional drug-specific information, testing the drugs for authenticity and FDA compliance, and relabeling them in accordance with FDA labeling.

The FDA authorized the importation program in accordance with section 804 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The move stems from President Biden’s “Executive Order on Promoting Competition in the American Economy,” which directed the FDA to help develop such programs.

Archive

  • AutoTL;DR@lemmings.worldBEnglish
    4·
    10 months ago

    This is the best summary I could come up with:

    Canada issued a warning Monday that it stands ready to defend its prescription drug supply from US importation plans—and also said the plans wouldn’t work for the US, anyway.

    “Bulk importation will not provide an effective solution to the problem of high drug prices in the US,” Health Canada said in a statement.

    The move stems from President Biden’s “Executive Order on Promoting Competition in the American Economy,” which directed the FDA to help develop such programs.

    “These proposals must demonstrate the programs would result in significant cost savings to consumers without adding risk of exposure to unsafe or ineffective drugs.”

    “The Department will not hesitate to take immediate action to address non-compliance, ranging from requesting a plan for corrective measures, issuing a public advisory or other forms of communication, to taking action on the licenses of regulated parties who contravene the export prohibition if warranted.”

    Stephen Ubl, CEO of the powerful trade group PhRMA—Pharmaceutical Research and Manufacturers of America—said in a statement that the group is “deeply concerned with the FDA’s reckless decision to approve Florida’s state importation plan” and claimed importation “poses a serious danger to public health.”

    The original article contains 576 words, the summary contains 190 words. Saved 67%. I’m a bot and I’m open source!